7 completed, 4 unknown. 6 Phase 1, 2 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Unknown 2 |
| Not applicable | 2 | Unknown 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow DWP14012: new trials by email Literature Review of DWP14012 trials Research Report on DWP14012
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease Fexuprazan, Esomeprazole - Gastro Oesophageal Reflux Disease | Phase 3 | Completed | Universitas Indonesia | 145 | 2024-08-28 | 2026-08-24 |
| Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects DWP14012, DWC202201 - Drug Drug Interaction | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 36 | 2022-10-26 | 2023-04-13 |
| Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects DWP14012, DWC202202, DWC202203 - Drug Drug Interaction | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 36 | 2022-09-21 | 2023-04-04 |
| Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects DWP14012, Aspirin - Drug Drug Interaction | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 24 | 2022-03-21 | 2023-04-05 |
| The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis DWP14012 - Reflux Esophagitis | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 332 | 2021-12-30 | 2023-04-14 |
| Treatment Effect According to Timing of Administration of DWP14012 40 mg DWP14012 - Erosive Esophagitis | Not applicable | Unknown | Konkuk University Medical Center | 186 | 2021-02-01 | 2021-05-17 |
| Treatment Effect According to Timing of Administration of DWP14012 40 mg DWP14012 - Erosive Esophagitis | Not applicable | Unknown | Daewoong Pharmaceutical Co. LTD. | 186 | 2020-11-17 | 2020-11-03 |
| Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs DWP14012, Celecoxib, Naproxen - Healthy Male Volunteers | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 110 | 2020-06-19 | 2020-07-29 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean DWP14012, Placebo - Healthy Volunteers | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 80 | 2018-11-01 | 2019-06-27 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) DWP14012, Esomeprazole, DWP14012 placebo - Erosive Gastroesophageal Reflux Disease | Phase 2 | Completed | Daewoong Pharmaceutical Co. LTD. | 211 | 2017-08-28 | 2020-09-03 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers DWP14012, Placebo, Esomeprazole - Healthy | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 120 | 2016-03-01 | 2017-04-25 |
Esophagitis, Peptic (1) · Gastroesophageal Reflux (1)
Daewoong Pharmaceutical Co. LTD. (9) · Konkuk University Medical Center (1) · Universitas Indonesia (1)
South Korea (9) · China (1) · Indonesia (1)
Ari Fahrial Syam, MD, PhD (1) · In Jin Jang, MD, PhD (1) · Jang In-Jin, MD, PhD (1)